Fordel StudiosZoetis CEO: AI Boosts 'Resilient' Animal Health Business
What Happened
Zoetis CEO Kristin Peck discusses animal health innovation, the 'incredibly resilient' animal health industry, and how AI is transforming health care. She talks with Katie Greifeld and Isabelle Lee on "The Close." (Source: Bloomberg)
Fordel's Take
Zoetis is deploying AI across veterinary diagnostics and drug discovery pipelines as a production capability, not a pilot. Their CEO described animal health as structurally insulated from macro volatility, with AI accelerating existing product workflows.
Regulated verticals like pharma don't behave like typical AI deployments. RAG pipelines built on generic LLM APIs break the moment FDA audit trail requirements apply — you need custom logging middleware, not just a vector store. Running GPT-4o for species-specific drug classification is just burning money when a fine-tuned smaller model on domain data outperforms it on accuracy and costs a fraction per inference.
What To Do
Use a fine-tuned small model instead of GPT-4o for regulated-vertical classification tasks because domain-specific training beats general capability and inference costs drop 10x.
Builder's Brief
What Skeptics Say
AI adoption claims from regulated life-sciences verticals in CEO TV interviews are rarely backed by specific metrics; 'AI boosts business' is brand positioning in a slow-moving regulated industry where real AI integration timelines are measured in years.
Cited By
React
Get the weekly AI digest
The stories that matter, with a builder's perspective. Every Thursday.